Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's After-Market Session

Author: Benzinga Insights | January 11, 2024 05:31pm

Gainers

  • Atreca (NASDAQ:BCEL) shares rose 45.6% to $0.34 during Thursday's after-market session. The market value of their outstanding shares is at $13.4 million.
  • Evoke Pharma (NASDAQ:EVOK) shares moved upwards by 16.45% to $0.99. The market value of their outstanding shares is at $3.3 million.
  • INVO Bioscience (NASDAQ:INVO) stock increased by 10.57% to $1.15. The market value of their outstanding shares is at $2.8 million.
  • Avenue Therapeutics (NASDAQ:ATXI) shares rose 9.25% to $0.19. The company's market cap stands at $2.5 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 6.82% to $0.26. The company's market cap stands at $6.7 million.
  • Monopar Therapeutics (NASDAQ:MNPR) shares increased by 6.22% to $0.47. The market value of their outstanding shares is at $6.9 million.

Losers

  • HeartBeam (NASDAQ:BEAT) shares decreased by 6.9% to $1.63 during Thursday's after-market session. The market value of their outstanding shares is at $42.9 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) shares declined by 6.74% to $0.13. The company's market cap stands at $31.6 million.
  • Sagimet Biosciences (NASDAQ:SGMT) stock declined by 5.62% to $6.72. The market value of their outstanding shares is at $153.8 million.
  • Rapid Micro Biosystems (NASDAQ:RPID) stock declined by 5.25% to $0.9. The market value of their outstanding shares is at $38.1 million.
  • Unicycive Therapeutics (NASDAQ:UNCY) stock fell 5.0% to $0.89. The market value of their outstanding shares is at $30.9 million.
  • 180 Life Sciences (NASDAQ:ATNF) stock fell 4.96% to $0.21. The company's market cap stands at $2.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ATNF ATXI BCEL BEAT EVOK INVO MNPR RPID SBFM SGMT TCRT UNCY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist